Skip to main content
Erschienen in: Cancer Causes & Control 2/2010

01.02.2010 | Original paper

Breast-feeding the last born child and risk of ovarian cancer

verfasst von: Linda Titus-Ernstoff, Judy R. Rees, Kathryn L. Terry, Daniel W. Cramer

Erschienen in: Cancer Causes & Control | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Conflicting reports regarding the relationship between breast-feeding and ovarian cancer risk suggest a possible influence of patterns of breast-feeding. We used logistic regression to examine breast-feeding in a large population of parous women who participated in a case–control study of ovarian cancer in New Hampshire and MA, USA. Risk of ovarian cancer was reduced in parous women who ever breast-fed (OR: 0.75; 95% CI: 0.62, 0.92), but evidence was limited for an influence of duration of breast-feeding and the number of children breast-fed. Compared to never breast-feeding, inverse associations were seen for breast-feeding all children (OR: 0.72; 95% CI: 0.58, 0.91) and for breast-feeding some children when the last born child was breast-fed (OR: 0.58; 95% CI: 0.37, 0.91). There was little evidence of reduced risk for those who breast-fed some children when the last born child was not breast-fed (OR: 0.91; 95% CI: 0.66, 1.26). Similar findings were noted in women with exactly two children and in those with two or more children. The protective influence of breast-feeding on ovarian cancer risk may be limited to women who breast-feed their last born child. These findings, which require confirmation by future studies, imply that breast-feeding resets pregnancy-related states that mediate ovarian cancer risk.
Literatur
1.
Zurück zum Zitat Whittemore AS, Harris R, Intyre J, The Collaborative Ovarian Cancer Group (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case–control studies. Am J Epidemiol 136(10):1184–1203PubMed Whittemore AS, Harris R, Intyre J, The Collaborative Ovarian Cancer Group (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case–control studies. Am J Epidemiol 136(10):1184–1203PubMed
2.
Zurück zum Zitat Kurian AW, Balise RR, McGuire V, Whittemore AS (2005) Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol 96:520–530CrossRefPubMed Kurian AW, Balise RR, McGuire V, Whittemore AS (2005) Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol 96:520–530CrossRefPubMed
3.
Zurück zum Zitat Hankinson SE, Colditz GA, Hunter DJ, Spencer TL, Rosner B, Stampfer MJ (1992) A quantitative assessment of oral contraceptive use and risk of ovarian cancer. Obstet Gynecol 80(4):708–714PubMed Hankinson SE, Colditz GA, Hunter DJ, Spencer TL, Rosner B, Stampfer MJ (1992) A quantitative assessment of oral contraceptive use and risk of ovarian cancer. Obstet Gynecol 80(4):708–714PubMed
4.
Zurück zum Zitat Beral V, Doll R, Hermon C, Peto R, Reeves G, Collaborative Group on Epidemiological Studies of Ovarian Cancer (2008) Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 371(9609):303–314CrossRefPubMed Beral V, Doll R, Hermon C, Peto R, Reeves G, Collaborative Group on Epidemiological Studies of Ovarian Cancer (2008) Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 371(9609):303–314CrossRefPubMed
5.
Zurück zum Zitat Zhang M, Xie X, Lee AH, Binns CW (2004) Prolonged lactation reduces ovarian cancer risk in Chinese women. Eur J Cancer Prev 13:499–502CrossRefPubMed Zhang M, Xie X, Lee AH, Binns CW (2004) Prolonged lactation reduces ovarian cancer risk in Chinese women. Eur J Cancer Prev 13:499–502CrossRefPubMed
6.
Zurück zum Zitat Chiaffarino F, Pelucchi C, Negri E, Parazzini F, Franceschi S, Talamini R et al (2005) Breastfeeding and the risk of epithelial ovarian cancer in an Italian population. Gynecol Oncol 98(2):304–308CrossRefPubMed Chiaffarino F, Pelucchi C, Negri E, Parazzini F, Franceschi S, Talamini R et al (2005) Breastfeeding and the risk of epithelial ovarian cancer in an Italian population. Gynecol Oncol 98(2):304–308CrossRefPubMed
7.
Zurück zum Zitat Purdie D, Green A, Brain C, Siskind V, Ward B, Hacker N et al (1995) Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case–control study. Int J Cancer 62:678–684CrossRefPubMed Purdie D, Green A, Brain C, Siskind V, Ward B, Hacker N et al (1995) Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case–control study. Int J Cancer 62:678–684CrossRefPubMed
8.
Zurück zum Zitat Purdie DM, Siskind V, Bain CJ, Webb PM, Green AC (2001) Reproduction-related risk factors for mucinous and nonmucinous epithelial ovarian cancer. Am J Epidemiol 153(9):860–864CrossRefPubMed Purdie DM, Siskind V, Bain CJ, Webb PM, Green AC (2001) Reproduction-related risk factors for mucinous and nonmucinous epithelial ovarian cancer. Am J Epidemiol 153(9):860–864CrossRefPubMed
9.
Zurück zum Zitat Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM et al (2002) Risk factors for invasive epithelial ovarian cancer: results from a Swedish case–control study. Am J Epidemiol 156(4):363–373CrossRefPubMed Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM et al (2002) Risk factors for invasive epithelial ovarian cancer: results from a Swedish case–control study. Am J Epidemiol 156(4):363–373CrossRefPubMed
10.
Zurück zum Zitat Soegaard M, Jensen A, Hogdall E, Christensen L, Hogdall C, Blaakaer J et al (2007) Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study. Cancer Epidemiol Biomarkers Prev 16(6):1160–1166CrossRefPubMed Soegaard M, Jensen A, Hogdall E, Christensen L, Hogdall C, Blaakaer J et al (2007) Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study. Cancer Epidemiol Biomarkers Prev 16(6):1160–1166CrossRefPubMed
11.
Zurück zum Zitat Gwinn ML, Lee NC, Rhodes PH, Layde PM, Rubin GL (1990) Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer. J Clin Epidemiol 43(6):559–568CrossRefPubMed Gwinn ML, Lee NC, Rhodes PH, Layde PM, Rubin GL (1990) Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer. J Clin Epidemiol 43(6):559–568CrossRefPubMed
12.
Zurück zum Zitat Danforth KN, Tworoger SS, Hecht JL, Rosner BA, Colditz GA, Hankinson SE (2007) Breastfeeding and risk of ovarian cancer in two prospective cohorts. Cancer Causes Control 18:517–523CrossRefPubMed Danforth KN, Tworoger SS, Hecht JL, Rosner BA, Colditz GA, Hankinson SE (2007) Breastfeeding and risk of ovarian cancer in two prospective cohorts. Cancer Causes Control 18:517–523CrossRefPubMed
13.
Zurück zum Zitat Jordan SJ, Green AC, Whiteman DC, Webb PM, Australian Ovarian Cancer Study Group, the Australian Cancer Study (Ovarian Cancer) (2007) Risk factors for benign serous and mucinous epithelial ovarian tumors. Obstet Gynecol 109(3):647–654PubMed Jordan SJ, Green AC, Whiteman DC, Webb PM, Australian Ovarian Cancer Study Group, the Australian Cancer Study (Ovarian Cancer) (2007) Risk factors for benign serous and mucinous epithelial ovarian tumors. Obstet Gynecol 109(3):647–654PubMed
14.
Zurück zum Zitat Booth M, Beral V, Smith P (1989) Risk factors for ovarian cancer: a case–control study. Br J Cancer 60:592–598PubMed Booth M, Beral V, Smith P (1989) Risk factors for ovarian cancer: a case–control study. Br J Cancer 60:592–598PubMed
15.
Zurück zum Zitat Titus-Ernstoff L, Perez K, Cramer DW, Harlow BL, Baron JA, Greenberg ER (2000) Menstrual and reproductive factors in relation to ovarian cancer risk. Br J Cancer 84(3):1–8 Titus-Ernstoff L, Perez K, Cramer DW, Harlow BL, Baron JA, Greenberg ER (2000) Menstrual and reproductive factors in relation to ovarian cancer risk. Br J Cancer 84(3):1–8
16.
Zurück zum Zitat Terry KL, Titus-Ernstoff L, McKolanis JR, Welch WR, Finn OJ, Cramer DW (2007) Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer. Cancer Epidemiol Biomarkers Prev 16(1):30–35CrossRefPubMed Terry KL, Titus-Ernstoff L, McKolanis JR, Welch WR, Finn OJ, Cramer DW (2007) Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer. Cancer Epidemiol Biomarkers Prev 16(1):30–35CrossRefPubMed
17.
Zurück zum Zitat Modugno F, Ness RA, Wheeler JE (2001) Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness. Ann Epidemiol 11(8):568–574CrossRefPubMed Modugno F, Ness RA, Wheeler JE (2001) Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness. Ann Epidemiol 11(8):568–574CrossRefPubMed
18.
Zurück zum Zitat Tung K, Goodman MT, Wu AH, McDuffie K, Wilkens L, Kolonel LN et al (2003) Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case–control study. Am J Epidemiol 158:629–638CrossRefPubMed Tung K, Goodman MT, Wu AH, McDuffie K, Wilkens L, Kolonel LN et al (2003) Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case–control study. Am J Epidemiol 158:629–638CrossRefPubMed
19.
Zurück zum Zitat Nagle CM, Olsen CM, Webb PM, Jordan SJ, Whiteman DC, Green AC et al (2008) Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors. Eur J Cancer 44:2477–2484CrossRefPubMed Nagle CM, Olsen CM, Webb PM, Jordan SJ, Whiteman DC, Green AC et al (2008) Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors. Eur J Cancer 44:2477–2484CrossRefPubMed
20.
Zurück zum Zitat Whiteman DC, Siskind V, Purdie DM, Green AC (2003) Timing of pregnancy and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 12:42–46PubMed Whiteman DC, Siskind V, Purdie DM, Green AC (2003) Timing of pregnancy and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 12:42–46PubMed
21.
Zurück zum Zitat Adami HO, Hsieh CC, Lambe M, Trichopoulos D, Leon D, Persson I, Ekbom A, Janson PO (1994) Parity, age at first childbirth, and risk of ovarian cancer. Lancet 344:1250–1254CrossRefPubMed Adami HO, Hsieh CC, Lambe M, Trichopoulos D, Leon D, Persson I, Ekbom A, Janson PO (1994) Parity, age at first childbirth, and risk of ovarian cancer. Lancet 344:1250–1254CrossRefPubMed
22.
23.
Zurück zum Zitat Cramer DW, Welch WR (1983) Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 71:717–721PubMed Cramer DW, Welch WR (1983) Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 71:717–721PubMed
Metadaten
Titel
Breast-feeding the last born child and risk of ovarian cancer
verfasst von
Linda Titus-Ernstoff
Judy R. Rees
Kathryn L. Terry
Daniel W. Cramer
Publikationsdatum
01.02.2010
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 2/2010
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-009-9450-8

Weitere Artikel der Ausgabe 2/2010

Cancer Causes & Control 2/2010 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.